Can We Better Manage COPD Populations Using Real-World Data?

Science & Innovation Webinar

Webinar Recorded on Oct. 6, 2021 
Sponsored by GSK  

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease. Exacerbations are a burden to the patient and health system and should drive treatment re-evaluation, following recommendations from GOLD as well as COPD Foundation. Additional considerations from real-world data may help in appropriate evaluation and interventional program development.

This presentation reviews real-world data related to the impact of comorbidities, including:

• Increased comorbid risks due to oral corticosteroid use
• Polypharmacy and resulting treatment complexity, and
• Benefits of medication synchronization.

In addition, the presentation provides an overview of current tools for assessment and management. By the end of the session, attendees will be able to:

• Review COPD guidelines and burden of disease
• Understand the different factors contributing to burden, and
• Discuss approaches for improving management.

Speakers:

• Ron Balkissoon, MD, MSc, FRCPC
  Staff Pulmonologist
  National Jewish Health
  Denver, Colorado
• Michael Bogart, PharmD
  Value Evidence & Outcomes
  GlaxoSmithKline

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: